267
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Characterization and ex vivo evaluation of curcumin nanoethosomes for melanoma treatment

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 72-82 | Received 16 May 2021, Accepted 24 Dec 2021, Published online: 06 Jan 2022

References

  • Adahoun MA, Al-Akhras M-AH, Jaafar MS, Bououdina M. 2017. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artif Cells Nanomed Biotechnol. 45(1):98–107.
  • Akbari J, Saeedi M, Enayatifard R, Morteza-Semnani K, Hassan Hashemi SM, Babaei A, Rahimnia SM, Rostamkalaei SS, Nokhodchi A. 2020. Curcumin niosomes (curcusomes) as an alternative to conventional vehicles: a potential for efficient dermal delivery. J Drug Delivery Sci Technol. 60:102035.
  • Akbarzadeh I, Tavakkoli Yaraki M, Ahmadi S, Chiani M, Nourouzian D. 2020. Folic acid-functionalized niosomal nanoparticles for selective dual-drug delivery into breast cancer cells: an in-vitro investigation. Adv Powder Technol. 31(9):4064–4071.
  • Bergonzi MC, Hamdouch R, Mazzacuva F, Isacchi B, Bilia AR. 2014. Optimization, characterization and in vitro evaluation of curcumin microemulsions. LWT - Food Science and Technology. 59(1):148–155.
  • Bragagni M, Mennini N, Maestrelli F, Cirri M, Mura P. 2012. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib. Drug Delivery. 19(7):354–361.
  • Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, Zhou L. 2012. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules. 17(5):5972–5987.
  • Chereddy KK, Coco R, Memvanga PB, Ucakar B, Des Rieux A, Vandermeulen G, Preat V. 2013. Combined effect of PLGA and curcumin on wound healing activity. J Control Release. 171(2):208–215.
  • Chinembiri T, Du Plessis L, Gerber M, Hamman J, Du Plessis J. 2014. Review of natural compounds for potential skin cancer treatment. Molecules. 19(8):11679–11721.
  • Domingues B, Lopes JM, Soares P, Pópulo H. 2018. Melanoma treatment in review. Immunotargets Ther. 7:35–49.
  • Dubey V, Mishra D, Dutta T, Nahar M, Saraf D, Jain N. 2007. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release. 123(2):148–154.
  • Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. 2007. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm. 332(1–2):1–16.
  • Gamal FA, Sayed OM, Abo El-Ela FI, Kharshoum RM, Salem HF. 2020. Treatment of basal cell carcinoma via binary ethosomes of vismodegib: in vitro and in vivo studies. AAPS PharmSciTech. 21(2):51.
  • Guy GP, Machlin SR, Ekwueme DU, Yabroff KR. 2015. Prevalence and costs of skin cancer treatment in the U.S., 2002 − 2006 and 2007 − 2011. Am J Prev Med. 48(2):183–187.
  • ICH. 2005. Validation of analytical procedures: text and methodology Q2(R1). Silver Spring (MD): US FDA; [accessed 2019 May 16]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/international-council-harmonisation-ich-guidance-documents.
  • Jaipakdee N, Jarukamjorn K, Putalun W, Limpongsa E. 2021. Permeation, stability and acute dermal irritation of miroestrol and deoxymiroestrol from Pueraria candollei var. mirifica crude extract loaded transdermal gels. Pharm Dev Technol. 26(9):967–977.
  • Jalalpure SS, Kumbar VM, Patil SR, Joshi SA, Bhat KG, Diwan PV. 2019. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: in vitro evaluation. J Lip Res. 29(3):291–311.
  • Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. 2002. Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. J Agric Food Chem. 50(13):3668–3672.
  • Jose A, Labala S, Ninave KM, Gade SK, Venuganti VVK. 2018. Effective skin cancer treatment by topical co-delivery of curcumin and STAT3 siRNA using cationic liposomes. AAPS PharmSciTech. 19(1):166–175.
  • Karakucuk A, Tort S. 2020. Preparation, characterization and antimicrobial activity evaluation of electrospun PCL nanofiber composites of resveratrol nanocrystals. Pharm Dev Technol. 25(10):1216–1225.
  • Kesharwani P, Banerjee S, Padhye S, Sarkar FH, Iyer AK. 2015. Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. Colloids Surf B Biointerfaces. 132:138–145.
  • Kolev TM, Velcheva EA, Stamboliyska BA, Spiteller M. 2005. DFT and experimental studies of the structure and vibrational spectra of curcumin. Int J Quantum Chem. 102(6):1069–1079.
  • Mahmood S, Mandal UK, Chatterjee B. 2018. Transdermal delivery of raloxifene HCl via ethosomal system: formulation, advanced characterizations and pharmacokinetic evaluation. Int J Pharm. 542(1–2):36–46.
  • Mangalathillam S, Rejinold NS, Nair A, Lakshmanan VK, Nair SV, Jayakumar R. 2012. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale. 4(1):239–250.
  • Manickam B, Sreedharan R, Chidambaram K. 2019. Drug/vehicle impacts and formulation centered stratagems for enhanced transdermal drug permeation, controlled release and safety: unparalleled past and recent innovations-an overview. Curr Drug Ther. 14(3):192–209.
  • Martins LG, Khalil NM, Mainardes RM. 2017. Application of a validated HPLC-PDA method for the determination of melatonin content and its release from poly(lactic acid) nanoparticles. J Pharm Anal. 7(6):388–393.
  • Nair RS, Billa N, Leong C-O, Morris AP. 2021. An evaluation of tocotrienol ethosomes for transdermal delivery using Strat-M® membrane and excised human skin. Pharm Dev Technol. 26(2):229–243.
  • Nair RS, Morris A, Billa N, Leong C-O. 2019. An evaluation of curcumin-encapsulated chitosan nanoparticles for transdermal delivery. AAPS PharmSciTech. 20(2):69.
  • Nair RS, Nair S. 2015. Permeation studies of captopril transdermal films through human cadaver skin. Curr Drug Deliv. 12(5):517–523.
  • Nair SR, Billa N, Morris A. 2021. A validated reverse-phase high performance liquid chromatography (RP-HPLC) method for the quantification of gamma- tocotrienol in tocotrienol rich fractions of crude palm oil. Curr Nutr Food Sci. 17:1–7.
  • Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE. 2014. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 35(10):3365–3383.
  • Naves LB, Dhand C, Venugopal JR, Rajamani L, Ramakrishna S, Almeida L. 2017. Nanotechnology for the treatment of melanoma skin cancer. Prog Biomater. 6(1–2):13–26.
  • Pan R, Zeng Y, Liu G, Wei Y, Xu Y, Tao L. 2020. Curcumin–polymer conjugates with dynamic boronic acid ester linkages for selective killing of cancer cells. Polym Chem. 11(7):1321–1326.
  • Pathan IB, Jaware BP, Shelke S, Ambekar W. 2018. Curcumin loaded ethosomes for transdermal application: formulation, optimization, in-vitro and in-vivo study. J Drug Delivery Sci Technol. 44:49–57.
  • Rajesh S, Sujith S. 2013. Permeation of flurbiprofen polymeric films through human cadaver skin. Int J Pharmtech Res. 5(1):177–182.
  • Raju YP, Hyndavi N, Chowdary VH, Nair RS, Basha JD. 2017. In vitro assessment of non-irritant microemulsified voriconazole hydrogel system. Artif Cells Nanomed Biotechnol. 45(8):1539–1547.
  • Sha K, Ma Q, Veroniaina H, Qi X, Qin J, Wu Z. 2021. Formulation optimization of solid self-microemulsifying pellets for enhanced oral bioavailability of curcumin. Pharm Dev Technol. 26(5):549–558.
  • Singh I, Nair RS, Gan S, Cheong V, Morris A. 2019. An evaluation of crude palm oil (CPO) and tocotrienol rich fraction (TRF) of palm oil as percutaneous permeation enhancers using full-thickness human skin. Pharm Dev Technol. 24(4):448–454.
  • Soni K, Mujtaba A, Akhter MH, Zafar A, Kohli K. 2020. Optimisation of ethosomal nanogel for topical nano-CUR and sulphoraphane delivery in effective skin cancer therapy. J Microencapsul. 37(2):91–108.
  • Sun M, Su X, Ding B, He X, Liu X, Yu A, Lou H, Zhai G. 2012. Advances in nanotechnology-based delivery systems for curcumin. Nanomedicine. 7(7):1085–1100.
  • Sun Y, Du L, Liu Y, Li X, Li M, Jin Y, Qian X. 2014. Transdermal delivery of the in situ hydrogels of curcumin and its inclusion complexes of hydroxypropyl-β-cyclodextrin for melanoma treatment. Int J Pharm. 469(1):31–39.
  • Tareen FK, Shah KU, Ahmad N, Asim.Ur.Rehman Shah SU, Ullah N. 2020. Proniosomes as a carrier system for transdermal delivery of clozapine. Drug Dev Ind Pharm. 46(6):946–954.
  • Tung BT, Hai NT, Son PK. 2017. Hepatoprotective effect of phytosome curcumin against paracetamol-induced liver toxicity in mice. Braz J Pharm Sci. 53(1):1–13.
  • Vijayan UK, Varakumar S, Sole S, Singhal RS. 2020. Enhancement of loading and oral bioavailability of curcumin loaded self-microemulsifying lipid carriers using Curcuma oleoresins. Drug Dev Ind Pharm. 46(6):889–898.
  • Wan S, Sun Y, Qi X, Tan F. 2012. Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion. AAPS PharmSciTech. 13(1):159–166.
  • Wang M-Z, Niu J, Ma H-J, Dad HA, Shao H-T, Yuan T-J, Peng L-H. 2020. Transdermal siRNA delivery by pH-switchable micelles with targeting effect suppress skin melanoma progression. J Control Release. 322:95–107.
  • Yallapu MM, Jaggi M, Chauhan SC. 2012. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today. 17(1–2):71–80.
  • Yang L, Wu L, Wu D, Shi D, Wang T, Zhu X. 2017. Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes. Int J Nanomed. 12:3357–3364.
  • Yu X, Du L, Li Y, Fu G, Jin Y. 2015. Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel. Biomed Pharmacother. 73:6–11.
  • Zhai Y, Xu R, Wang Y, Liu J, Wang Z, Zhai G. 2015. Ethosomes for skin delivery of ropivacaine: preparation, characterization and ex vivo penetration properties. J Liposome Res. 25(4):316–324.
  • Zhang Y, Bush X, Yan B, Chen JA. 2019. Gemcitabine nanoparticles promote antitumor immunity against melanoma. Biomaterials. 189:48–59.
  • Zhou X, Hao Y, Yuan L, Pradhan S, Shrestha K, Pradhan O, Liu H, Li W. 2018. Nano-formulations for transdermal drug delivery: a review. Chin Chem Lett. 29(12):1713–1724.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.